PAPA JOSEPH C — SEC insider filings

SEC reporting owner CIK 1242215. 35 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 35 filings on record, filed 2020-09-16 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Emergent BioSolutions Inc. (EBS)President and CEO, Director61 leg · 60,000 sh · $349,800—8
Prometheus Biosciences, Inc. (RXDX)Director61 leg · 15,000 sh · $285,000—12
Candel Therapeutics, Inc. (CADL)Director102 legs · 38,032 sh · $73,059—9
Bausch Health Companies Inc. (BHC)Director8——29
Milestone Pharmaceuticals Inc. (MIST)Director4——6
Bausch & Lomb Corp (BLCO)CEO & Chairman, Director1——2

Insider filings — PAPA JOSEPH C

FiledFormIssuerReported transactionsSource
2026-10-024Candel Therapeutics, Inc. (CADL)Grant/award (A): 1,325 (derivative) @ $8.68EDGAR
2026-07-014Candel Therapeutics, Inc. (CADL)Grant/award (A): 1,331 (derivative) @ $8.64EDGAR
2026-06-244Candel Therapeutics, Inc. (CADL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2026-06-124Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 77,000 (derivative) @ $0EDGAR
2026-05-014Emergent BioSolutions Inc. (EBS)Grant/award (A): 187,708 @ $0EDGAR
2026-04-024Candel Therapeutics, Inc. (CADL)Grant/award (A): 2,795 (derivative) @ $4.11EDGAR
2026-03-054Emergent BioSolutions Inc. (EBS)Tax withholding (F): 37,055 @ $8.44 · Grant/award (A): 252,194 (derivative) @ $0EDGAR
2025-07-154Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 100,000 · Grant/award (A): 100,000 (derivative) · Grant/award (A): 100,000 (derivative)EDGAR
2025-06-264Candel Therapeutics, Inc. (CADL)Grant/award (A): 64,239 @ $4.67EDGAR
2025-06-184Candel Therapeutics, Inc. (CADL)Grant/award (A): 14,240 (derivative) @ $0EDGAR
2025-06-124Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-05-154Emergent BioSolutions Inc. (EBS)Purchase (P): 60,000 @ $5.83EDGAR
2025-03-124Emergent BioSolutions Inc. (EBS)Grant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2025-03-104Emergent BioSolutions Inc. (EBS)Grant/award (A): 282,500 @ $0 · Grant/award (A): 282,500 (derivative) @ $0EDGAR
2024-09-054Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2024-06-274Candel Therapeutics, Inc. (CADL)Grant/award (A): 14,240 (derivative) @ $0EDGAR
2024-03-154Emergent BioSolutions Inc. (EBS)Grant/award (A): 750,000 (derivative) @ $0EDGAR
2023-06-294Candel Therapeutics, Inc. (CADL)Grant/award (A): 14,240 (derivative) @ $0EDGAR
2023-06-164Prometheus Biosciences, Inc. (RXDX)Disposition to issuer (D): 7,278 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 27,340 (derivative) · Disposition to issuer (D): 22,652 (derivative) · Disposition to issuer (D): 2,165 (derivative) · +1 moreEDGAR
2023-06-024Prometheus Biosciences, Inc. (RXDX)Other (J): 10,000 @ $0 · Other (J): 10,000 @ $0EDGAR
2023-05-194Prometheus Biosciences, Inc. (RXDX)Grant/award (A): 2,278 @ $0EDGAR
2022-12-124Candel Therapeutics, Inc. (CADL)Purchase (P): 3,014 @ $1.70 · Purchase (P): 35,018 @ $1.94EDGAR
2022-08-104Candel Therapeutics, Inc. (CADL)Grant/award (A): 28,480 (derivative) @ $0EDGAR
2022-05-204Prometheus Biosciences, Inc. (RXDX)Grant/award (A): 22,551 (derivative) @ $0EDGAR
2022-05-124Bausch Health Companies Inc. (BHC)Option exercise (M): 116,697 · Option exercise (M): 183,522 · Option exercise (M): 65,911 · Tax withholding (F): 33,714 @ $9.40 · Grant/award (A): 116,697 (derivative) · Option exercise (M): 116,697 (derivative) @ $9.40 · +4 moreEDGAR
2022-05-094Bausch & Lomb Corp (BLCO)Grant/award (A): 472,222 @ $0 · Grant/award (A): 1,868,131 (derivative) @ $0EDGAR
2022-03-074Bausch Health Companies Inc. (BHC)Tax withholding (F): 12,643 @ $23.61EDGAR
2022-03-024Bausch Health Companies Inc. (BHC)Option exercise (M): 208,231 · Tax withholding (F): 100,351 @ $24.35 · Tax withholding (F): 13,183 @ $24.35 · Tax withholding (F): 13,206 @ $24.35 · Tax withholding (F): 5,115 @ $24.06 · Grant/award (A): 208,231 (derivative) · +1 moreEDGAR
2021-11-164Prometheus Biosciences, Inc. (RXDX)Grant/award (A): 2,165 (derivative) @ $0EDGAR
2021-09-154Bausch Health Companies Inc. (BHC)Tax withholding (F): 3,549 @ $29.19 · Tax withholding (F): 5,010 @ $28.66EDGAR
2021-03-164Prometheus Biosciences, Inc. (RXDX)Purchase (P): 15,000 @ $19EDGAR
2021-03-104Bausch Health Companies Inc. (BHC)Option exercise (M): 317,089 · Grant/award (A): 108,254 @ $0 · Tax withholding (F): 231,188 @ $32.97 · Option exercise (M): 317,089 (derivative)EDGAR
2021-03-054Bausch Health Companies Inc. (BHC)Grant/award (A): 74,150 @ $0 · Grant/award (A): 196,464 (derivative) @ $0EDGAR
2021-03-034Bausch Health Companies Inc. (BHC)Tax withholding (F): 28,192 @ $31.42EDGAR
2020-09-164Bausch Health Companies Inc. (BHC)Tax withholding (F): 3,623 @ $15.40 · Tax withholding (F): 5,115 @ $15.91EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1242215 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs